leukemia, myelogenous, chronic, bcr-abl positive (13)
leukemia, myeloid, acute (13)
apoptosis (8)
antineoplastic agents (7)
pyrimidines (7)
piperazines (6)
mutation (5)
butyrates (4)
humans (4)
anemia, aplastic (3)
antimetabolites, antineoplastic (3)
antineoplastic combined chemotherapy protocols (3)
blast crisis (3)
cytarabine (3)
drug resistance, neoplasm (3)
fusion proteins, bcr-abl (3)
hematopoietic stem cell transplantation (3)
tumor cells, cultured (3)
antigens, cd (2)
bone marrow transplantation (2)
deoxycytidine (2)
diseases of the blood and blood-forming organs (2)
genes, abl (2)
imatinib mesylate (2)
influenza a virus, h1n1 subtype (2)
monocytes (2)
multiple sclerosis (2)
precursor cell lymphoblastic leukemia-lymphoma (2)
primary myelofibrosis (2)
protein kinase inhibitors (2)
protein-tyrosine kinases (2)
purpura, thrombotic thrombocytopenic (2)
rc633-647.5 (2)
receptors, tumor necrosis factor (2)
signal transduction (2)
single-domain antibodies (2)
thrombocythemia, essential (2)
tumor necrosis factor-alpha (2)
adamantane (1)
adenosine triphosphate (1)
adult (1)
allografts (1)
anti-arrhythmia agents (1)
atherosclerosis (1)
atp binding cassette transporter, subfamily b, member 1 (1)
autologous (1)
autologous stem-cell transplantation (1)
azacitidine (1)
benzamides (1)
binding sites (1)